KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT)

NCT02042963 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2014-01-23

No results posted yet for this study

Summary

KNOW-KT (KoreaN cohort study for Outcome in patients With KT: A 9-year Longitudinal cohort study of the Korean adult KT patients), funded by Korea Center for Disease Control and Prevention (KCDC) was established in 2012 by a group of transplant physicians, transplant surgeons, nephrologists, epidemiologists, and biostatisticians in Korea.

We aimed to establish an adult KT cohort, to investigate the renal allograft outcomes, mortality, complications, and to explore traditional or nontraditional risk factors for morbidity and mortality. We established a bio-bank to integrate clinical and biological information. Here, we report design and method of the KNOW-KT.

Conditions

  • Kidney Transplant Recipients
  • Complications After Kidney Transplant

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER
  • Chonbuk National University Medical School

    collaborator UNKNOWN
  • Gachon University Gil Medical Center

    collaborator OTHER
  • Keimyung University Dongsan Medical Center

    collaborator OTHER
  • Korea University

    collaborator OTHER
  • Kyungpook National University Hospital

    collaborator OTHER
  • Samsung Medical Center

    collaborator OTHER
  • Medical Research Collaborating Center, Seoul, Korea

    collaborator OTHER
  • Yonsei University

    collaborator OTHER
  • Seoul National University College of Medicine

    collaborator UNKNOWN
  • Seoul National University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2021-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02042963 on ClinicalTrials.gov